Doctor Teal's Epsom Salt Recalled for Improper Storage Conditions
Family Dollar Stores is recalling Doctor Teal's Pure Epsom Salt packages distributed April 30–June 10, 2022 due to improper storage temperature conditions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for manufacturing process deviation (improper storage temperature conditions). The source does not report illnesses or injuries, and the hazard concerns process control rather than confirmed contamination or structural defect.
Plain-English summary
Family Dollar Stores, LLC is recalling Doctor Teal's Pure Epsom Salt products due to manufacturing process deviations. The recalled products include 6 LB packages (SKU 999355) and 2 LB packages (SKU 909223) that were held outside appropriate storage temperature conditions, violating current good manufacturing practices.
The affected products were distributed to specific Family Dollar Store locations nationwide between April 30, 2022 and June 10, 2022. This is an FDA Class II recall addressing process control deviations in product storage and handling.
The recalled product
- Product
- DOCTOR TEALS PURE EPSOM SALT UNSCENTED 6 LBS SKU 999355 Ready in case EPSOM SALTS 2 LB SKU 909223 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug
- Hazard
- improper-storage-temperature
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 999355
- 909223
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27